Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Filings indexed 511 across all filing types
Latest filing 2023-04-27 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于科美诊断技术股份有限公司2022年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the 2022 annual special audit opinion on the deposit and use of raised funds by Kemei Diagnostic Technology Co., Ltd. It includes specific financial figures about the amount raised, usage, balance, and management of the funds, as well as compliance with regulatory requirements. The document references regulatory guidelines and includes an auditor's conclusion on the raised funds usage. This is a specialized audit report focusing on the use of raised capital, not a full annual report or earnings release. It is not a simple announcement or certification but contains substantive financial and compliance information related to the audit of raised funds. Therefore, it fits the category of Audit Report / Information (AR). FY 2022
2023-04-27 Chinese
科美诊断技术股份有限公司2022年度募集资金存放与使用情况鉴证报告
Regulatory Filings
2023-04-27 Chinese
科美诊断技术股份有限公司关于续聘2023年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of the audit firm 信永中和会计师事务所 for the company's 2023 audit. It details the audit firm's qualifications, independence, integrity, and the procedures followed for the reappointment, including approvals by the audit committee, independent directors, and the board of directors. It explicitly states that the appointment is subject to approval at the 2022 annual shareholders' meeting. The document does not contain any actual audit report, financial statements, or audit results. It is essentially a notice about the audit firm appointment process and related governance matters, not the audit report itself. Therefore, this fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information about audit firms and their appointment, excluding full annual reports. FY 2022
2023-04-27 Chinese
科美诊断技术股份有限公司独立董事关于第二届董事会第三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters discussed at the second board meeting of the second session, including profit distribution plan, use of raised funds, appointment of audit firm, internal control evaluation report, and remuneration plans for directors and senior management. It references compliance with laws and regulations and supports submitting these matters to the 2022 annual shareholders' meeting. The document is a formal opinion letter from independent directors rather than a full annual report or audit report. It does not contain detailed financial statements or comprehensive financial performance data. It is not a certification letter or a brief announcement but a detailed opinion on board meeting matters. This fits best under Board/Management Information (MANG) as it relates to board meeting opinions and governance matters, including audit firm appointment and remuneration plans.
2023-04-27 Chinese
科美诊断技术股份有限公司2022年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through an initial public offering (IPO) by 科美诊断技术股份有限公司. It includes specifics on the amount raised, usage of funds, cash management of idle funds, regulatory approvals, and audit opinions from an accounting firm and a sponsoring institution. The document references regulatory guidelines related to the management and use of raised funds and includes a detailed table of fund usage. The content focuses on the company's fundraising activities, the deployment of those funds, and compliance with regulatory requirements. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not an announcement of a report publication, nor is it a full annual or interim financial report. It is a substantive update on capital raising and fund usage.
2023-04-27 Chinese
科美诊断技术股份有限公司2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the 2022 annual report summary of 科美诊断技术股份有限公司, containing detailed financial data for the year 2022, including total assets, net profit, revenue, quarterly financial data, shareholder information, business overview, industry analysis, and risk disclosures. It includes comprehensive financial performance and operational details typical of an official yearly report. The length is over 11,000 characters, indicating it is a full report rather than a brief announcement. The presence of audited financial figures and management discussion confirms it is an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.